Page last updated: 2024-10-15

alpha-hydroxyglutarate and Basal Ganglia Diseases

alpha-hydroxyglutarate has been researched along with Basal Ganglia Diseases in 1 studies

2-hydroxyglutarate : A dicarboxylic acid anion obtained by deprotonation of at least one of the carboxy groups of 2-hydroxyglutaric acid.
2-hydroxyglutaric acid : A 2-hydroxydicarboxylic acid that is glutaric acid in which one hydrogen alpha- to a carboxylic acid group is substituted by a hydroxy group.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Craigen, WJ1
Jakobs, C1
Sekul, EA1
Levy, ML1
Gibson, KM1
Butler, IJ1
Herman, GE1

Other Studies

1 other study available for alpha-hydroxyglutarate and Basal Ganglia Diseases

ArticleYear
D-2-hydroxyglutaric aciduria in neonate with seizures and CNS dysfunction.
    Pediatric neurology, 1994, Volume: 10, Issue:1

    Topics: Basal Ganglia Diseases; Blindness; Brain Diseases, Metabolic; Chromosome Aberrations; Chromosome Dis

1994